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Abstract
‘‘Hypomyelination and Congenital Cataract’’, HCC (MIM #610532), is an autosomal recessive disorder characterized by
congenital cataract and diffuse cerebral and peripheral hypomyelination. HCC is caused by deficiency of Hyccin, a protein
whose biological role has not been clarified yet. Since the identification of the cell types expressing a protein of unknown
function can contribute to define the physiological context in which the molecule is explicating its function, we analyzed
the pattern of Hyccin expression in the central and peripheral nervous system (CNS and PNS). Using heterozygous mice
expressing the b-galactosidase (LacZ) gene under control of the Hyccin gene regulatory elements, we show that the gene is
primarily expressed in neuronal cells. Indeed, Hyccin-LacZ signal was identified in CA1 hippocampal pyramidal neurons,
olfactory bulb, and cortical pyramidal neurons, while it did not colocalize with oligodendroglial or astrocytic markers. In the
PNS, Hyccin was detectable only in axons isolated from newborn mice. In the brain, Hyccin transcript levels were higher in
early postnatal development (postnatal days 2 and 10) and then declined in adult mice. In a model of active myelinogenesis,
organotypic cultures of rat Schwann cells (SC)/Dorsal Root Ganglion (DRG) sensory neurons, Hyccin was detected along the
neurites, while it was absent from SC. Intriguingly, the abundance of the molecule was upregulated at postnatal days 10 and
15, in the initial steps of myelinogenesis and then declined at 30 days when the process is complete. As Hyccin is primarily
expressed in neurons and its mutation leads to hypomyelination in human patients, we suggest that the protein is involved
in neuron-to-glia signalling to initiate or maintain myelination.
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Introduction
Hypomyelinating leukoencephalopathies of the central nervous
system (CNS) are inherited white matter disorders (WMDs)
characterized by permanent myelin deficiency. The term ‘‘hypo-
myelination’’ also applies to congenital disorders of the peripheral
nervous system (PNS) characterized by hypomyelination in the
presence or absence of signs of active demyelination [1–3].
The myelin sheath is a modified plasma membrane wrapped
with a spiral pattern around axonal segments between the nodes of
Ranvier. This highly specialized membrane is composed of
multiple layers of myelin that have a protein-lipid-protein-lipid-
protein architecture, and are modified extensions of oligodendro-
cytes in the CNS, or SC in the PNS. In both the CNS and PNS,
the deposition and maintenance of myelin is complex and involves
different cells and several axo-glial signalling pathways [4,5] that
have only partly been revealed [6].
Hypomyelination and Congenital Cataract, HCC (MIM
#610532), is an autosomal recessive disorder first identified in
five unrelated families with ten subjects affected by congenital
cataract and diffuse cerebral and peripheral hypomyelination
[7,8]. While bilateral cataract was present at birth or within the
first month of life, developmental delay was noticed at the end of
the first year of life after initially normal psychomotor develop-
ment. The neurological picture was characterized by pyramidal
and cerebellar signs as well as muscle weakness and wasting of the
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lower limbs, indicating also PNS involvement. Indeed peripheral
neuropathy was confirmed by neurophysiological and neuropath-
ological studies. The clinical course was slowly progressive and the
majority of patients became wheelchair-bound at around 8-9 years
of life. Brain magnetic resonance imaging (MRI) showed diffuse
hypomyelination with superimposed areas of abnormal signal
intensity consistent with increased water content [9]. Sural nerve
biopsies were characterized by a slight to severe reduction of
myelinated fiber density with several axons surrounded by a thin
myelin sheath or devoid of myelin. Uncompacted myelin sheaths,
which in some fibers appeared redundant and irregularly folded,
were occasionally seen [7].
HCC patients are affected by mutations in the gene FAM126A
(previously named DRCTNNB1A). FAM126A encodes for a
521aa protein of unknown function, which we named Hyccin.
In the first description of the disease, we identified two mutations
affecting a splice-site, while the third one was a missense. At the
protein level, all three mutants lead to absence or severe reduction
of Hyccin protein [7].
Subsequently, the clinical spectrum of HCC was extended with
the identification of a consanguineous family with a large
intragenic deletion encompassing two exons of the FAM126A
gene [10]. Notably, these patients did not display congenital
cataract . Most recently Biancheri et al. (Archives of Neurology, in
press) reported nine novel HCC patients from seven unrelated
families. Although the latter study found significant clinical
variability in the occurrence and age of onset of cataract as well
as the severity and progression of neurological symptoms, MRI
features of hypomyelination combined with increased periventric-
ular white matter water content are consistently observed,
distinguishing HCC from other forms of hypomyelinating
leukoencephalopathies.
In order to define the cellular origin of HCC pathogenesis, we
investigated Hyccin expression in the nervous system.
We found that Hyccin is predominantly expressed in the CNS,
where it is localized in neurons but not in myelinating cells. In
peripheral neurons, Hyccin is of low abundance and detectable
only at early postnatal ages.
Moreover, we show that in DRG neurons and SC mixed
cocultures, an in vitro model of myelination, the expression of
Hyccin precedes the phases of active formation of the myelin
sheath.
Results
To analyze the cellular expression of the Hyccin molecule, we
took advantage of the promoterless LacZ gene (encoding a
cytoplasmic b-galactosidase) integrated into the Fam126a locus of
heterozygous (Het) Hyccin mice to express LacZ under control of
the regulatory elements of the Fam126a gene. The endogenous
Fam126a locus was targeted for modification by homologous
recombination in embryonic stem (ES) cells using the selectable
marker Neo. Fam126a coding sequence spans from exon 2 to exon
10 of the gene. The mutant allele was designed to replace the first
coding exon (exon #2) (starting from amino acid 3), the intron in
between and exon # 3 with a LacZ-Neo cassette (Fig. 1A–B). This
deletion included the site of the IVS2+1G-A mutation, which was
identified in a subgroup of our HCC patients and which leads to
skipping of exon #2 with the generation of an aberrant Fam126a
transcript and absence of Hyccin protein by immunoblot analysis
[7].
The construct was delineated to drive LacZ under the control of
the Fam126a promoter by removing the LacZ start codon and
fusing it in frame with the first 3 amino acids of the Fam126a
coding sequence. This design allowed us to detect the tissue
location and developmental appearance of endogenous Hyccin by
LacZ staining of Het mice. Hyccin Het mice were indistinguish-
able from wild type (WT) littermates based on body weight, cage
behaviour, spontaneous locomotor activity, and reproductive
performance (data not shown). The mutant allele is also disrupted
regarding the expression of Hyccin and thus presents a functional
null allele. The phenotypic consequences of homozygous deletion
of Hyccin will be reported separately.
Hyccin-LacZ signal was evaluated in brain and sciatic nerves
isolated from Het males at postnatal days P2, P10 and P30.
In the CNS, at P2 (Fig. 2 A, B and C) Hyccin gene activity was
found in the olfactory nuclei and in the prefrontal cortex (A), in the
piriform cortex (B and C arrowheads) and in the cerebral cortex
with marked labeling in layer 5 (B and C arrows) and lower signal
in layer 2. In addition, in the hippocampus LacZ labelling was
detected in the pyramidal neurons of the CA1, CA2 and CA3
fields, while it was almost not detectable in the dentate gyrus. At
P10 (Fig. 2 D,E and F), labeling was found in the same regions as
at P2. However, in the cerebral cortex, expression in layer 2 was
more prominent, with similar intensity than in layer 5 (E, arrows).
In the hippocampus, labeling was more intense at the level of CA1
and CA2 fields compared to CA3 (F, arrow). At P30 (Fig. 2 G,H
and I), the layers 2 and 5 of the cerebral cortex were positive at all
levels along the anteroposterior axis with less intense signal
compared to previous stages (H arrows). Interestingly, in the
hippocampus the signal was confined to CA1 and CA2 fields, with
a sharp boundary between CA2 and CA3 (I, arrow). Labeling was
also present in olfactory nuclei (G), and in ventromedial
hypothalamic nuclei (I, arrowhead).
To further confirm the principally neuronal expression pattern
of the Hyccin gene, coronal sections of previously LacZ stained
brains were probed with antibodies directed against the neuron-
specific nuclear protein NeuN, the oligodendroglial 29,39-Cyclic-
Figure 1. Generation of mice expressing lacZ under control of
the Hyccin gene regulatory elements. Panel A: Schematic
representation of the Fam126a locus and engineering of a Fam126a -
LacZ allele. A segment containing exons 2 and 3 were replaced with a
cassette containing a modified b-galactosidase coding sequence (LacZ)
and a drug resistance minigene comprised of the phosphoglycerate
kinase promoter (PGKp), a bacterial promoter (EM7p) and neomycin
phosphotransferase (Neor), flanked by loxP sequences. The numbers
below the line representing the genomic sequence indicate base pairs.
Panel B: A representative PCR analysis of tail genomic DNA from wild-
type (WT), heterozygous (Het) homozygous LacZ knockin mice and
documenting Fam126a gene deletion.
doi:10.1371/journal.pone.0032180.g001
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nucleotide 39-phosphodiesterase (CNP) or the astrocyte marker
glial fibrillar acidic protein (GFAP) (Fig. 3).
Notably, the LacZ signal was detected in cells immunopositive
for NeuN (Fig. 3A), while it did not associate with CNP (Fig. 3B) or
GFAP (Fig. 3C) markers.
To confirm the results independent of the gene targeting, we
applied in situ hybridization and immunofluorescence to WT mice.
RNA in situ-hybridization was performed on coronal sections
from P30 WT mouse brain via an anti-digoxygenin Hyccin
700 bp antisense oligonucleotide probe [11]. Hyccin signal was
most intense at the level of the cortex and the hippocampus
(Figure 4A and B). In the cerebral cortex, Hyccin labelling was
expressed strongest in layer 5.
By immunofluorescence, Hyccin fluorescent signal was detected
in the hippocampal segments where the labeling was strikingly
more intense in the CA1 and CA2 regions when compared to the
CA3 or to the dentate gyrus (Fig. 5A), in agreement with the gene
expression pattern found by LacZ staining. Moreover, in
consistency with the LacZ staining analyses, Hyccin colocalized
with the NeuN marker (Fig. 5B). The specificity of the antiserum
directed against Hyccin was determined by comparison of protein
lysates from human healthy controls (n = 3) and HCC patient
fibroblasts (n = 3) (mouse and human hyccin protein sequence are
97% homologous). Western blot analysis indicated that the
antibody recognized a protein of the expected size of 54 kDa in
extracts of control fibroblasts, while no signal was observed in
patients’ fibroblasts (Figure S1-A). These results were confirmed in
HeLa cells, known to express hyccin protein, by peptide
competition, in which the primary antibody directed against
Hyccin was pre-incubated with a 5-fold molar excess of the
immunizing peptide before being exposed to the antigen (Figure
S1-B).
The temporal regulation of Hyccin expression in the CNS was
quantified in total brain lysates isolated from P2, P10, P30, P60
WT animals by real-time PCR. Hyccin transcripts were
significantly more abundant at postnatal days 2 and 10 and then
decreased by approximately 75% in adult animals (Fig. 6).
Figure 2. Analysis of b-galactosidase activity in the CNS from P2 (A,B,C), P10 (D,E,F), P30 (G,H,I) hyccin Het mice (n=3). In the CNS,
Hyccin is expressed in olfactory nuclei (A,D,G), in distinct layers of the neocortex (arrows in B,C, E,H) and in the hippocampal region with stronger
expression in CA1 and CA2 fields as compared to CA3 (F,I arrows); dentate gyrus is negative. Other sites of expression include the prefrontal cortex,
the piriform cortex (arrowheads B and D) and the ventromedial hypothalamic nuclei (I, arrowhead). Scale bars are 1000 micron (A,–F) and 2000
micron (G–I).
doi:10.1371/journal.pone.0032180.g002
Figure 3. Immmunocolocalization analysis of Hyccin-LacZ
activity and the markers NeuN (A), CNP (B) and GFAP (C) in
the CNS hyccin from P10 Hyccin Het mice (n=3). Cryostat
sections (40 u thickness) from the CNS of LacZ stained Het mice were
immunostained with primary antibodies raised against the different
markers. Note that the LacZ signal colocalizes only with the NeuN
nuclear neuronal signal. Representative pictures are shown.
doi:10.1371/journal.pone.0032180.g003
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As concerns the PNS, sciatic nerves from P2, P10, P30 and P60
Hyccin Het mice were stained with 5-bromoindolyl-o-galactopyr-
anoside (Bluo-Gal) staining solution for optic and electron
microscopy. After -galactosidic cleavage, Bluo-Gal precipitates in
form of fine birefringent crystals, whereas X-gal gives rise to an
amorphous precipitate. This property of Bluo-Gal results in greatly
enhanced sensitivity of the staining method for LacZ and allows
for optimal morphological resolution in electron microscopy [12].
At all ages examined, Bluo-Gal staining was not detected in
peripheral nerves of Het mice by light or electron microscopy,
indicating that b-galactosidase was not very abundantly expressed
under control of regulatory elements of the Hyccin gene.
Heterozygous Ebf 2 null mice, in which the Ebf2 coding region
was replaced by LacZ, were used as positive controls [13].
Interestingly, Bluo-Gal precipitate was detected in peripheral
nerves of mice homozygously expressing LacZ under control of the
Hyccin gene, though confined to postnatal day 2.
In this cohort of mice, LacZ signal localized to axons
surrounded by myelin-forming SC (arrowhead in Fig. 7A).
Hence, Hyccin protein levels were compared in total brain and
sciatic nerve lysates by immunoblot analysis at the age of postnatal
day P10.
Consistent with the Bluo-Gal staining, Hyccin protein levels
were of very low abundance in sciatic nerves when compared to
total brain lysates (Fig. 7B).
To further define the expression of Hyccin in the PNS, primary
rat SC and DRG sensory neurons were immunostained with the
anti-Hyccin antibody. The specificity of the antibody for
immunocytochemistry was confirmed by colocalization studies in
HeLa cells transiently transfected with a GFP-hyccin expression
vector (Fig. 8A).
Hyccin positivity was observed along the neurites, while no
specific signal was detected in SC. These results were confirmed by
double labelling of Hyccin and respectively phosphorylated
neurofilament and S100 protein. (Fig. 8 B,C). Anyhow, further
experiments are needed to clarify the expression and function of
Hyccin in the PNS.
Finally, to correlate the temporal evolution of Hyccin expression
with active myelinogenesis, we established a 30 days organotypic
DRG culture. The transcripts of myelin protein zero (MPZ) were
quantified to control the correctness of the process of myelination.
Interestingly, Hyccin mRNA levels increased during the first 10–
15 days of the culture, when myelin forming cells are
differentiating, and then decreased of about the 40% at 30 days
when SC fully expressed the myelin markers MPZ and myelin
basic protein (MBP) and when myelin sheath were formed (Fig. 9,
ABC).
In conclusion, in the CNS, Hyccin is expressed in a subset of the
neurons, and its transcripts are significantly more abundant in
young mice at early stages of postnatal development correlating
with the onset of myelination. The abundance of Hyccin is lower
Figure 4. RNA in situ hybridization on brain sections from P30 WT mice reveals an expression pattern in agreement with principal
neuronal expression. Coronal brain sections were hybridized with a Hyccin antisense 700 bp probe. Panel A: High-magnification image of
hippocampus shows the strongest labeling of Hyccin in the CA1, 2 region compared to the CA3 region and dentate gyrus (DG). Scale bar is 200 m.
Panel B: High-magnification image of the cerebral cortex revealed a stronger labeling of Hyccin in deep cortical layers (V/VI) compared to superficial
layers (II–III). Scale bar is 200 m.
doi:10.1371/journal.pone.0032180.g004
Figure 5. Immunofluorescence analysis of Hyccin on brain
sections from P30 WT mice. Panel A: Coronal brain sections were
probed with anti-hyccin polyclonal antibody. High-magnification image
of hippocampus shows the most intense labeling of Hyccin in the CA1,
2 regions compared to the CA3 and dentate gyrus (DG). Scale bar is
200 m. Panel B: Coronal brain sections were probed with anti-Hyccin
polyclonal antibody or with anti-NeuN antibody. Hyccin and NeuN
immunoreactivity were detected by respectively Alexa 499 and 546
conjugated secondary antibodies. High magnification image of CA1
region of the hippocampus. Note the colocalization between hyccin
and the neuronal marker in the merge. Scale bars are 80 m.
doi:10.1371/journal.pone.0032180.g005
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in the mature PNS, where the protein was detected only in null
Hyccin mice carrying two copies of the LacZ allele.
Finally, in an in vitro model of myelinogenesis, i.e. a mixed
population of SC and sensory neurons, Hyccin is up-regulated in
the steps of active myelination thus supporting the hypothesis of its
active involvement in the formation of the myelin sheath.
Discussion
Our study aimed to establish the cellular expression in the
nervous system of a novel protein, Hyccin, responsible for the
etiology of the autosomal recessive hypomyelinating disorder
HCC.
In the past few years our understanding of the nosology and
physiopathology of inherited white matter diseases has greatly
improved, though a significant number of patients with cerebral
white matter involvement still remain without diagnosis despite
extensive investigations. Hypomyelination is the single largest
category among undiagnosed cases [3,14–17]. The prototype of
defined hypomyelinating leukoencephalopathies is Pelizaeus-
Merzbacher Disease (PMD) caused by a primary defect of myelin
proteolipid protein (PLP) expressed in oligodendrocytes; however,
other hypomyelinating disorders are related to primary neuronal
or astrocytic dysfunctions, including Salla disease caused by
SLC17A5 gene mutations, Pelizaeus Merzbacher-Like Disease
due to GJA12 mutations, or Alexander disease caused by
mutations affecting the astrocytic GFAP [18–24]
The discovery that the hereditary leukoencephalopathy HCC is
caused by mutations affecting the gene FAM126A, which encodes
for Hyccin, a protein of unknown function, raised the question
how this molecule may function, and why functional loss may lead
to hypomyelination.
Hyccin is expressed at low levels in a variety of adult tissue, and
its transcripts are most abundant in the heart, spleen, and cerebral
cortex (data not shown).
Phylogenetic and multiple alignment analysis of human
FAM126A identify a homolog called FAM126B, whose function
and pattern of expression are unknown. Phylogenetic analysis and
software-based prediction tools do not allow any classification of
Hyccin into any specific protein family, and do not suggest any
previously defined functional domain.
Figure 6. Real-time PCR analysis of Hyccin transcripts in total brain lysates from P2 (n=12), P10 (n=12), P30 (n=6) and P60 (n=6)
WT mice. Results are expressed as mRNA fold increase relative to calibrator (p2) normalized to housekeeping genes (b-actin and GAPDH).
Quantitative data were reported as median values with first and third quartiles (1st-3rd q) and minimum and maximum value (Min-max). * = p,0.01.
doi:10.1371/journal.pone.0032180.g006
Figure 7. Analysis of Hyccin expression in the PNS. Panel A:
Semithin sections of sciatic nerves isolated from Hyccin KO mice (n = 3)
were stained with Bluo-Gal and analyzed by electron microscopy.
Arrows point to Hyccin-LacZ signal. Panel B. Immunoblot analysis of
hyccin protein in sciatic nerve lysates isolated from P10 WT mice as
compared to total brain lysates. Note that Hyccin protein levels is very
low in the mature sciatic nerve sample. GAPDH was utilized as a sample
loading control.
doi:10.1371/journal.pone.0032180.g007
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Therefore, as a step towards understanding the pathogenesis of
HCC, we established the specific expression pattern of Hyccin in
the CNS and PNS. For this purpose, we generated a new mouse
model expressing LacZ under control of the regulatory elements of
the Hyccin gene and thus allow monitoring Hyccin gene activity
by b-galactosidase staining. LacZ activity was evaluated in early
postnatal mice (P2 and P10) and adult animals. Notably, the
protein is differentially expressed in neuronal cells in distinct layers
of the cerebral cortex and in the hippocampal region. Importantly
Hyccin was not detected in cells which immunostained positive for
the oligodendroglial marker, CNP, or the astrocyte molecule
GFAP.
Since LacZ signal reflects activity of the modified allele but is
only an indication for the expression of Hyccin (as post-
transcriptional effects may have an influence as well), these results
were confirmed independently by RNA in situ-hybridization and
immunofluorescence analysis. Confocal microscopy of Hyccin
signal allowed also a quantitative comparison of its labeling in the
different regions of the hippocampus.
The detection of strong expression of a gene involved in
myelination in the CA1 and CA2 regions of the hippocampus,
when compared to CA3 or the dentate gyrus is not surprising.
Indeed, these regions are characterized by densely packed
pyramidal somata which result immunopositive for Hyccin and
NeuN signal and which are characterized by fully myelinated
long-projecting axons. In the CA3 region the pyramidal neurons
display a minor density, while in the dentate gyrus the neuronal
population is composed of interneurons and granule cells, which
only project to CA3 through non-myelinated mossy fibres.
Myelination is a strictly regulated process. In the mouse, it starts
approximately at birth in the spinal cord, and in the brain is
largely accomplished in almost all regions by around 45–60
postnatal days. When tested by real-time PCR on total brain
lysates, Hyccin expression is highest in newborn mice and at early
stages of postnatal development and then decades in adult animals,
thus indicating an up-regulation of the molecule expression
correlating with an early phase of myelinogenesis.
In the PNS, Hyccin-LacZ signal was not detected in Het
animals at any age examined, and was identified only by electron
microscopy at postnatal day 2 in homozygous mice in which both
alleles are expressing LacZ.
When tested in vitro, in primary cultures of SC or DRG neurons,
Hyccin was visualized on the neurites, while it was absent in SC.
Notably, temporal analysis of Hyccin expression in organotypic
Figure 8. Immunofluorescence analysis of hyccin expression in DRG neurons and Schwann cell cultures. Panel A: Immunocolocalization
of GFP-Hyccin transiently transfected in Hela cells and the anti-hyccin polyclonal antibody. Representative images of Hela cells transfected with GFP-
Hyccin and immunostained with anti-hyccin polyclonal antibody 24 hr after transfection. Hyccin immunoreactivity was detected by Alexa546
conjugated secondary antibodies. The arrows in the merge panel show colocalization of the two signals in the cytosol. Final magnification 636. Scale
bars represent 100 m. Panel B: DRG neurons cultures were immunostained with an anti-hyccin antibody and an anti-phosphorylated neurofilament.
Hyccin and Neurofilament immunoreactivities were detected respectively by Alexa488 and Alexa546 conjugated secondary antibodies. The merge
panel shows positivity of the two signals in the neurites. Final magnification 406. Panel C: Schwann cells cultures were immunostained with an anti-
hyccin polyclonal antibody and an anti-S100 monoclonal antibody. Hyccin and S100 immunoreactivities were detected respectively by Alexa488 and
Alexa546 conjugated secondary antibodies. Final magnification 1006.
doi:10.1371/journal.pone.0032180.g008
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cultures of DRG neurons and SC highlighted its possible role in
myelination. This in vitro system has been extensively used to study
development and regeneration of peripheral nerves, and diseases
including hereditary sensory and motor neuropathies, and it
constitutes a valuable model to analyze particularly the early steps
of myelination [25–30]. In this model, Hyccin was up-regulated at
days 10 and 15, a step of the culture which precedes myelin
formation and the expression of classical myelin markers. This result
seems to be consistent with the hypothesis of Hyccin as an axonal
signal instructing myelination and stimulating SC to synthesize
myelin proteins and lipids, and to extend myelin sheaths.
Previous reports from the literature showed Hyccin transcripts
in neurons as well as in cells of the oligodendrocytic and astrocytic
lineage [31,32]. It is well possible that indeed a minimal amount of
Hyccin mRNA may be expressed also in cells other that neurons
but that the protein is not detectable or not present.
In our paper we analyzed mainly Hyccin protein pattern of
expression and to support the data we followed an integrated
approach based on in vivo b-galactosidase gene activity data plus
immune-based experiments.
Moreover, Hyccin main neuronal expression here shown is in
accordance with brain and spinal cord data reported on the Allen
Brain Atlas website, a database of genes expression pattern of the
mouse brain completed by RNA in situ hybridization (http://
www.brain-map.org).
In this work, we have shown that Hyccin is neuronally
expressed. Considering the hypomyelination in patients with
mutations affecting the Hyccin gene, we suggest that this protein is
part of the signals that regulate neuron-to-glia cross-talk at the
onset of myelination, or regarding myelin maintenance. Indeed,
neurons utilize a battery of signals to control the differentiation of
associated myelinating glial cells. In the PNS, axonal molecules
involved in the induction or maintenance of myelin include
Neuregulin-1 [33,34] the shedding enzymes BACE and TACE
[35,36], BDNF signaling to the neurotrophin receptor p75 [37],
and axonal prion protein [38], while axonal signalling to
myelinating glia has been less well understood in the CNS [6].
Hyccin might be a co-factor or regulator of neuronal molecules
already known to mediate the neuron-glia interplay; however its
relevance for CNS myelin indicates that the protein may be an
important part of an independent, yet to be identified signalling
mechanism.
Materials and Methods
Antibodies
The antibodies and dilutions used in the study include the
following: polyclonal antibody against Hyccin (D-15) (Santa Cruz;
Biotechnology) (1:50 for tissue immunofluorescence [IF], 1:500 for
Western blot [WB]); polyclonaly anti-hyccin antibody (Novus
Figure 9. Hyccin expression levels in organotypic DRG cultures. Panel A: Cells were maintained in culture for the times indicated and analysis
of MPZ mRNA was utilized as a reference for myelination in the culture. Results are expressed as mRNA fold increase relative to calibrator (10 days)
normalized to housekeeping genes (b-actin and GAPDH) For each sample data are represented as means 6SEM (n = 3) and .p values were ,0.05
compared to control. Panel B: Total cellular lysates were isolated at the times indicated and subjected to immunoblot analysis for the myelin markers
MPZ and MBP. An antibody against GAPDH was used as an internal control. Panel C: At 30 days cell cultures were fixed, stained with 1% Sudan Black
in 70% ethanol and analyzed by optic microscopy. Bright-field micrographs confirm the presence of myelin sheaths with Ranvier nodes (white arrows)
surrounding th axons.
doi:10.1371/journal.pone.0032180.g009
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Biologicals) (1:100 for immunocytochemistry); monoclonal antibody
against phosphorylated (SMI31) neurofilaments (NF) (Sternberger
Monoclonals Inc.) (1:250 for IF); monoclonal anti-Glial Fibrillary
Acidic Protein (GFAP), clone GA5 (Millipore) (1:400 for immuno-
histochemistry [IHC]; monoclonal anti-neuronal Nuclei (NeuN),
clone A60 (Millipore), (1:1000 for IHC and 1:150 in IF); monoclonal
anti- 29,39-cyclic nucleotide 39 phosphodiesterase (CNP), clone 11-
5B (Millipore), (1:50 for IHC); Fab fragments anti-Digoxigenin-
Alkaline phosphatase (AP), (1:2000 for in situ-hybridization), (Roche);
monoclonal anti-myelin basic protein (MBP) clone MAB382,
(Chemicon) (1:3000 in WB); monoclonal anti myelin protein zero
() (1:1000 in WB); polyclonal anti-glyceraldeyde 3 phosphate
deydrogenase (I-19) (Santa Cruz, Biotechnology), a monoclonal
anti-S100 antibody (Abcam), a monoclonal anti-myelin protein zero
(MPZ), P07 extracellular domain, Astexx Ltd. & Co. KEG, Graz,
Austria. Rabbit anti-goat IgG horseradish peroxidase-conjugated
(1:4000 for WB) was from ZYMED (Invitrogen), while the anti-
mouse Dako EnVision+ System-HRP Labelled Polymer was from
Dako Group. Hyccin fluorescent signal was detected following
tyramide signal amplification according to manufacturer’s instruc-
tions (PerkinElmer Life Sciences).
In confocal microscopy, secondary antibody reaction was
carried out using donkey anti mouse Alexa Fluor 488, donkey
anti goat Alexa Fluor 633, rabbit anti mouse Alexa Fluor 633,
chicken anti rabbit Alexa Fluor 657 antibodies (1:600) (all from
Molecular Probes Inc.).
Generation and genotyping of Hyccin knock-out mice
The mouse Fam126a locus spans 130 kilobases (kb), and exons 2
to 11 encode the protein. VelociGene technology was used to
replace a segment of Fam126a including exons 2 and 3
corresponding to an 11-kb genomic region (base pairs [bp] 2378
to 2473 of exon 2, 2473 to 13230 of intron 2 and 13231 to 13324 of
exon 4 [Ensemble Accession Number: ENSMUSG00000028995;
GenBank Accession number: NM_053090] with a b-galactosidase
(LacZ)/neomycin (Neor) cassette [39]. The replacement cassette
was formed by the LacZ reporter gene and by a phosphoglycerate
kinase promoter-Neor selection cassette flanked by LoxP sequences.
Briefly, a bacterial artificial chromosome (BAC) containing Fam126a
coding region and 800 bp of total flanking sequences (clone X from
release II of a 129/SvJ BAC library obtained from Incyte
Genomics; Wilmington, DE) was modified to generate a BAC-
based targeting vector, which was linearized and used to replace
Fam126a gene in F1H4 (C57BL/6:129 hybrid) mouse embryonic
stem (ES) cells. Correctly targeted ES cells were identified by using
the loss of native allele (LONA) assay, as described [11]. Two
independently correctly targeted ES cell lines were used to generate
chimeric male mice that were complete transmitters of ES-derived
sperm. Chimeras were bred to C57BL/6 females to generate F1
heterozygous mice, which were genotyped by LONA assays and
identified by LacZ histochemical assays. F1 mice were crossed with
C57BL/6mice and the F2 offspring was used to maintain the line in
a mixed 129/C57BL/6 genetic background. For each experiment,
Hyccin heterozygous (Het) male mice derived from F2 heterozygous
intercrosses were used.
Genotyping was completed by PCR on genomic DNA isolated
from tail samples.
The sequences of primers used for the LacZ and for Fam126a
genes are the following:
LAC Z allele (360 bp): Forward: 59 AAA GAC GCA GTT
CTG CAT GG 39, Reverse: 59 TCA TTC TCA GTA TTG TTT
TGC C 39 FAM126a WT allele (280 bp): Forward:59 GTA CCA
AAC ACC AGC ATG GA 39, Reverse: 59 TCA CTC TGT GGC
TCC TGG AT 39.
All the Animal experiments were approved by the Animal Care
and Use Committee of Istituto di Fisiologia Clinica, CNR, Pisa,
Italy (Project # 187).
Cell cultures
HeLa cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM), supplemented with 10% fetal calf serum (FCS),
penicillin and streptomycin in a humified 5% CO2 atmosphere at
37uC. All cell culture products were purchased from Gibco/
Invitrogen (Merelbeke, Belgium).
The GFP-tagged ORF clone of FAM126A (GFP-hyccin)
purchased from Origene was transiently transfected in Hela cells
using the Turbofect TM in vitro Transfection Reagent (Fermentas)
according to manufacturer’s instructions (1 ug DNA complexed
with 1,5 u/well of transfection reagent). Hyccin expression was
evaluated by immunofluorescence or western blot analysis 24 h
after transfection.
Organotypic dorsal root ganglia (DRG) cultures were estab-
lished from 15-day-old embryos using previously established
methods [12]. After extracting them using a sterile technique, 30
to 35 DRG were removed from each embryo, pre-treated with
trypsin (Hanks’solution 0.25%), and triturated to provide a
suspension of DRG cells in a medium supplemented with 15%
bovine calf serum, and nerve growth factor 5 ng/mL final
dilution. This suspension was plated on a collagen substrate in
flexible molded plastic Aclar dishes, and 156104 cells were placed
in each dish. As for each embryo we established 4 cultures, we
obtained enough material to perform a time-course (30 days)
analysis of hyccin expression and myelination features by both
molecular biology and light microscopy evaluations.
For myelination staining, DRG cultures were washed in PBS,
fixed in Trump’s fixative at 4uC overnight, post-fixed the following
day in 2% osmium tetroxide and stained with 1% Sudan Black in
70% ethanol. Each culture was assessed for the presence or
absence of myelin and for the morphological appearance of all
observed fibres.
Establishment of primary SC and DRG neurons cultures has
been described previously [29,30].
Neuronal cultures were established from 15 day-old wild-type
rat embryos. After extracting them using a sterile technique, 35 to
40 DRG were removed from each embryo, pre-treated with
trypsin (Hanks’solution 0.25%), and triturated to provide a
suspension of DRG cells in a medium supplemented with 15%
newborn calf serum (NCS), ascorbic acid (100 ug/mL final
dilution) and nerve growth factor (NGF) (5 ng/mL final dilution).
This suspension was plated on collagen-coated ACLAR dishes at a
density of 156104 cells/dish. After 48 hr, the cells were treated
with Fudr medium (neurobasal medium, 15% NCS, NGF,
ascorbic acid and 1025 M 5-fluoro-29-deoxyuridine and uridine)
(Invitrogen, Srl, Italy) for two 48-hr cycles to eliminate fibroblasts
growth. Cultures were used for molecular and immunocytochem-
istry evaluations.
SC cultures were established from 3 day-old rat pups. Sciatic
nerves of the newborn rats were dissected and dissociated [15]. SC
were grown in DMEM/F12 medium (Invitrogen) supplemented
with 10% fetal calf serum (FCS), penicillin and streptomycin for
48 hr. Cytosine arabinoside (Ara-C) 1025 M was added after
48 hr and the treatment prolonged for further 48 hr resulting in
SC cultures that were 99% pure and were used for molecular and
immunocytochemistry evaluations.
Primary fibroblasts were isolated from cutaneous biopsies of
HCC patients (n = 3) and healthy controls (n = 3). Written
informed consent was received from all participants.
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Quantitative PCR
Quantitative real-time PCR experiments (qRT-PCR) were
carried out on total brain lysates from C57/BL6J WT mice (P2,
P10, P30, P60), different organs from C57/BL6J WT mice (P30)
and from rat Dorsal Root Ganglion (DRG)-Schwann cocultures
(10 days, 15 days, 30 days of culture).
For DRG, and Schwann cells total RNA was extracted using
the RNeasy Micro Kit (Qiagen) according to the manufacturer’s
protocol including DNase treatment; for mouse tissues total RNA
was extracted using the RNeasy Lipid Kit (Qiagen). Quality and
quantity of RNA were analyzed using a NanoDrop spectropho-
tometer. The cDNA was synthesized from 100 ng of total RNA
with the iScript cDNA Synthesis Kit (Bio-Rad Laboratories). Each
RNA sample was controlled for genomic DNA contamination
without reverse transcriptase addition into cDNA synthesis
mixture. qRT-PCR was performed in triplicate with the 26
Power Sybr Green PCR Master Mix (Applied Biosystem) in
CFX96 Real-time PCR detection system (Bio-rad). The 15 ml
PCR mixture contained diluted cDNA corresponding to 3 ng of
total RNA and 0.2 mM of each primer. Relative expression levels
were normalized to calibrator sample by using the comparative Ct
(DDCt) method and the geometric average of a set of two
housekeeping genes [40–42]. (GAPDH, b-Actin) by the Bio-Rad
CFX manager software. For each specific primers set, the
efficiency was .95% and a single product was seen on the
melting curve analysis. Specific primers for FAM126a (NM_
001191969 rattus norvegicus, NM_053090 mus musculus), beta-
actin (ACTB, NM_031144 rattus norvegicus, NM_007393 mus
musculus), Glyceraldehyde-3-phosphate dehydrogenise (GAPDH,
NM_017008 rattus norvegicus, NM_008084 mus musculus) and
Myelin Protein Zero (MPZ, NM_017027) were designed through
Beacon Designer 2.0 Software and are listed in Methods S1.
RNA In situ-hybridization of mouse brain
In-situ hybridization was performed on brains isolated from P30
C57/BL6J wild-type (WT) mice. The mice were anaesthetized
with isofluorane (Isofluorane-vet, Merial) and decapitated. Upon
sacrifice, brains were incubated in PAF 4% in PBS ON at 4uC,
cryo-protected with sequential incubations with 15% sucrose/PBS
O.N. at 4uC and 30% sucrose/PBS until submerged.
Then brains were embedded in OCT and immediately frozen
in cold isopentane. Sections (10 um) were cut by a cryostat and
mounted on glass slides (VWR International).
Sections were delimitated with DakoPen (Dako Group) washed
in PBS permeabilized with RIPA buffer two times for 10 min and
fixed in PAF 4% in PBS for 10 min at RT.
After three washes in PBS, sections were treated with an
acetylation step with 0.25% thrietanolamine and acetic anhydride.
The pre-hybridization reaction was performed for 1 h at 70uC
using the hybridization buffer containing 50% formamide/26
NaCl 150 mM, Na3Citrate 15 mM (SSC), 56Denhardt Solution,
Herring sperm DNA 500 mg/ml (Invitrogen), Yeast RNA 250 ug/
ml (Ambion).
We used a set of digoxigenin-labeled riboprobes that span
700 bp of FAM 126a transcript.
Probes were obtained from PCR amplification (primers probe 1:
mDRC sense 1: T7 TAATACGACTCACTATAGGAGATACA-
GAATTAACAGGTC; mDRC antisense1: SP6 ATTTAGGT-
GACACTATAGATGCAGACAGAGTGACGCT; probes 2:
mDRC sense 2: T7 TAATACGACTCACTATAGGGAAAGA-
CAAGAGTTCTTTAG; mDRC antisense 2: SP6 ATTTAGGT-
GACACTATAGAAATGTCAATACTTCAAACCT).
PCR products (20 mg) were purified with QIAquick PCR
Purification Kit (QIAGEN) and used to generate the sense and
antisense riboprobes (Riboprobe Combination system-SP6/T7,
Promega Corporation, DIG RNA Labeling Mix, Roche Diagnos-
tic). Probes were purified by RNA Cleanup and Concentration Kit
(QIAGEN) and measured with NanoDrop spectrophotometer.
Each riboprobe was transcribed as sense, which specifically labeled
the target mRNA, and antisense, to control for unspecific binding
or for background staining due to the endogenous alkaline
phosphatase activity of the tissue.
For the hybridization reaction, slides were incubated in
hybridization buffer with addition of 100 ng/ml of probes ON
in a humidified chamber at 70uC. The washing steps included
incubations with formamide 50%/26SSC, 0.1% Tween-20 (post-
hybridization buffer) for two times 1 h at 70uC, Subsequently the
samples were treated with Buffer B1 (Maleic acid 100 mM
pH 7.5, NaCl 150 mM, 0.1%Tween-20) blocked with 10% Fetal
Calf Serum (FCS)/B1 for 30 min at RT and incubated ON at 4uC
with anti-digoxigenin-AP antibody in 10%FCS/B1.
Slides were washed twice with B1, incubated in Tris-HCl
100 mM pH 9.5, MgCl2 50 mM, NaCl 100 mM, 0.1% Tween-20
for 30 min at RT, and finally detected with Nitroblue tetrazolium
Chloride (NBT)- 5-Bromo-4-Chloro-3-indolyl phosphate, tolui-
dine salt (BCIP).
When the colour reaction was completed, sections were washed
with 0.1%Tween-20/PBS and dried [11].
Expression analysis of the b-galactosidase reporter gene
and immunohistochemistry (IHC)
Brains were isolated from postnatal day (P) P2, P10, P30, P60
Hyccin Het mice , fixed 3 h with fixing solution (glutaraldehyde
0.2%, ethylene glycol tetracetic acid (EGTA) 100 mM, 2%
Paraformaldehyde (PAF) in PB buffer, i.e. phosphate buffer
0.12 M, pH 7.4), washed once with PB buffer and three times
with Wash Buffer (MgCl2 0.1 M, 1%, sodium deoxycholate 2%
NP-40 in PB buffer).
The tissues were embedded in 2.5% agarose in PB buffer.
Coronal sections (100 um) were cut with a microtome HM 650 V
(Bioptica), washed 3 times with Wash Buffer and with PB, and
then incubated with X-Gal solution (X-Gal 100 mg/ml, ferrocy-
anide potassium 2 mg/ml, ferricyanide potassium 1.64 mg/ml in
Wash Buffer) for 3 h (P2, P10 mice) and ON (P30, P60 mice) at
37uC.
Sections were analyzed with Neurolucida software (Micro-
BrightField) connected to a Nikon E-800 microscope via a colour
CCD camera.
For the colocalization studies, coronal sections from brains of
P30 Hyccin Het mice were cut with the microtome (1500 um) and
processed for X-Gal staining. Following the staining and the
washes, tissues were incubated in 4% PAF/PBS for 1 h at 4uC,
cryo-protected with incubation in 30% sucrose/PBS ON at 4uC,
embedded in OCT (Tissue-Tek Sakura Finetek) and stored at
280uC.
Free-floating coronal sections (40 um) were cut on a cryostat
(Leica CM1900UV), processed with 0.5% SDS/PBS for antigen
retrieval, incubated with 0.3%, H2O2 1,0% CH3OH/PBS,
washed three times in PBS, blocked with 15%/Horse Serum/
0.1% Tween/PBS (blocking solution) for 30 min at RT and
incubated with the primary antibodies diluted in blocking solution
ON at 4uC. The following day the sections were washed three
times with PBS, blocked for 30 min in blocking solution and
incubated with the secondary antibody anti-mouse Dako EnVision
for 30 min a RT in the dark. Sections were washed with PBS,
were developed with DAB (Dako Group), and mounted with
Vectashield Mounting Medium (Vector Laboratories).
Hyccin Expression in Neuronal Cells
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e32180
Immunofluorescence analyses
Brains were isolated from P30 C57/BL6J WT mice and fixed in
4% PAF/PBS ON at 4uC and cryo-protected with sequential
incubations with 15% sucrose/PBS O.N. at 4uC and 30%
sucrose/PBS until submerged. The tissues were hence incubated
in a 1:1 solution containing OCT and 30% sucrose/PBS for
1 hour in agitation at RT, and finally embedded in OCT.
Free-Floating sections (40 um) were cut on a cryostat, were
rinsed with PBS, incubated with 0.5 M Ammonium Chloride for
antigen retrieval, rinsed with PBS, blocked with 3% Bovine Serum
Albumin (BSA)/0.1% TritonX-100 (blocking solution) in PBS for
30 min at RT, and incubated with primary antibodies diluted in
blocking solution ON at 4uC.
Sections were washed three times with 0.1% Triton X-100/
PBS, incubated with the secondary antibodies diluted in blocking
solution 1 hour at RT, washed two times with 0.1% Triton X-
100/PBS and two times with PBS, and mounted on polysinated-
coated slides with mounting medium Vectashield.
Images were obtained using a Leica TCS SL confocal
microscope equipped with argon/He-Ne laser sources and an
HCX PL APO CS 63.061.40 oil objective. During image
acquisition, the 488 and 633 laser were set at 20% energy and
the emission range was between 500–550 and 650 and 700 nm for
Hyccin-Alexa 488 and NF-Alexa 633, respectively. The photo-
multiplier voltage gain was set to eliminate cell autofluorescence.
Single plane images were taken at the center of cell thickness.
Cell immunofluorescence studies were performed in HeLa cells
transiently transfected with a GFP-hyccin expression vector and in
cultures of rat SC and DRG sensory neurons. Cells were fixed for
15 min in 4% paraformaldehyde in PBS at RT and then
permeabilized with ice-cold methanol for 10 min at 220uC. Cells
were incubated with 5% FBS in PBS-TRITON 0.3% for 30 min
and then with the primary antibodies in a humidified box at 4uC
ON. After three washes in PBS, cells were incubated with the
secondary antibodies conjugated with Alexa Fluor 488 or 633 for
1 h. Following a PBS rinse, the coverslip (mounting with
Vectashield reagent (Vector)) and the ACLAR dishes were
observed at a confocal microscope.
Images were obtained using a Leica TCS SL confocal
microscope equipped with argon/He-Ne laser sources and an
HCX PL APO CS 63.061.40 oil objective. The photomultiplier
voltage gain was set to eliminate cell autofluorescence. Single
plane images were taken at the center of cell thickness.
Micrographs from DRG sensory neurons and primary SC were
taken with an Olympus DP-70 digital microscope camera attached
to an Olympus Provis AX-60 module fluorescence microscope
with a 406 or 1006 objective lens.
Western blot
Lysates of HeLa cells, fibroblasts, brain, sciatic nerves and
organotypic DRG cultures were prepared directly in ice cold
RIPA buffer [50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1%
NP40, 0.25% Na-deoxycholate,1 mM PMSF, 1.100 proteinase
inhibitor cocktail]. Samples were sonicated and recovered by
centrifugation (5810 R; Eppendorf) for 15 min, at 12.0006g, 4uC.
The total protein content was determined in supernatants by the
Bio-Rad Protein Assay kit (Bio-Rad); equal protein amounts were
loaded onto 12–15% polyacrilamide gel and separated by SDS-
PAGE.
Proteins were transferred onto polyvinylidene difluoride mem-
branes (Immobilon PVDF; Millipore). After the blocking reaction
(5% BSA in PBS/0.1% Tween 20), membranes were incubated for
1 h at RT with primary antibody diluted in 1% BSA/PBS. Blots
were rinsed and incubated with horseradish peroxidase rabbit anti-
goat IgG secondary antibody and visualized using the ECL
detection method (GE Health care). The sample protein signal
was normalized to the respective GAPDH signal. For peptide
competition assays, Hyccin (D-15) antibody diluted 1:500 in 1%
BSA/PBS was pre-incubated for 1 h at RT with 5 fold of the
competing Hyccin D-15 homologous peptide and centrifuged
(20,0006g for 15 min). The supernatant was applied onto a PVDF
membrane to which the HeLa cells lysate had been transblotted.
Electron Microscopy
Sciatic nerves were isolated from P2, P10, P30 and P60 Hyccin
Het mice, fixed 1 h with 2% glutaraldehyde/PB, washed and
incubated in Bluo-Gal staining solution (0.4 mg/ml Bluo-Gal,
3.1 mM potassium ferricyanide/ferrocyanide, 10 mM MgCl2,
0.12 M PB, pH 7.4) ON at 37uC After washing in PB, samples
were post-fixed for 1 hr at RT with 1% osmium tetroxide in
0.06 M sodium cacodylate buffer. Nerves were dehydrated and
rapidly infiltrated in propylene oxide and epoxy resin to minimize
the solubilization of Bluo-Gal precipitates and then embedded.
Ultrathin sections (70 nm) were performed using a Reichert
ultramicrotome (Leica Microsystems, Wetzlar, Germany), col-
lected on copper grids and not counterstained to better visualize
Bluo-Gal crystals. All the samples were analysed under a JEM-
1011 electron microscope (JEOL Ltd, Tokio, Japan) at 80 kV.
Statistical analysis
Descriptive analyses were firstly performed; quantitative data
were reported as median values with first and third quartiles (1st–
3rd q) and minimum and maximum value (Min-max). The
comparison of quantitative data in different groups of observations
was evaluated by the non parametric analysis of variance Kruskal-
Wallis test); the post-hoc analysis was made by the Dunn’s test.
All the statistical tests were two-sided and a p value less than
0.05 was considered as statistically significant. The software
‘‘Statistica’’ (StatSoft Co., Tulsa, OK, USA) was used for all the
statistical analyses.
Supporting Information
Figure S1 Immunoblot analysis of hyccin. Panel A: Total
cellular lysates of fibroblasts from controls (C) and HCC affected
individuals (Pt). Panel B: Total cellular lysates of Hela cells in the
absence (2) or presence of competing peptide (+). An antibody
against GAPDH was used as an internal control.
(TIF)
Methods S1 Specific primers for quantitative real-time
PCR of FAM126a (NM_001191969 rattus norvegicus,
NM_053090 mus musculus), beta-actin (ACTB, NM_
031144 rattus norvegicus, NM_007393 mus musculus),
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH,
NM_017008 rattus norvegicus, NM_008084 mus muscu-
lus) and Myelin Protein Zero (MPZ, NM_017027).
(DOC)
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